The 6th US Circuit Court of Appeals ruled on September 25 that states can apply local gambling laws to Kalshi's sports event contracts, rejecting the prediction market provider's argument that federal law preempts state regulation.
Paramount Skydance reached settlements with California and 11 other state attorneys general who sued to block its proposed $110 billion acquisition of Warner Bros. Discovery. The settlement includes terms requiring 30 films annually and penalties for non-compliance.
The GOP-majority North Carolina State Board of Elections approved new, stricter guidelines for counting mail-in ballots on Friday, just hours before the state became the first in the nation to mail out ballots for the 2026 midterm elections. The last-minute rule changes come amid broader Trump administration efforts to restrict mail voting, creating uncertainty and administrative challenges for election officials.
California Governor Gavin Newsom signed AB 2624 into law, expanding privacy protections for immigration-service workers. Critics warn the law could affect investigative journalism and free-speech rights, with the measure nicknamed after journalist Nick Shirley.
A Washington state court issued a final order requiring prediction market platform Kalshi to immediately stop accepting and brokering new event contracts tied to sports, elections, politics, and entertainment categories.
Texas Governor Greg Abbott ordered state regulators to pause approvals for new data center projects seeking connection to the state's electric grid, citing concerns about surging electricity demand threatening grid reliability. The directive affects approximately 1,800 pending projects and requires audits before any new approvals.
Multiple U.S. states are implementing measures to regulate pharmacy benefit management companies that oversee prescription drug coverage for health insurers, as part of efforts to reduce medication costs for consumers.
Bipartisan efforts are emerging at federal and state levels to regulate pharmacy benefit managers (PBMs), with proposals including barring companies from owning both PBMs and retail pharmacies. Two states have already enacted such restrictions, while federal legislation has gained support from both conservative Republicans and progressive Democrats.
